Additionally, while our studies demonstrate a substantial role for megalin expression in maintaining PT function, our work here does not address how Lrp2 KO alters SGLT2 expression or activity, or how megalin defends against WD-induced kidney disease. The gene discussed is LRP2; the disease is kidney disorder.